Global Policy Platform
How can countries and regions boost the biotech industry within their borders? Working with several member companies, BIO developed a Global Policy Platform to serve as a roadmap for policymakers seeking to create an environment for the biotech industry to grow and prosper.
BIO CEO & Investor Conference
BIO recently hosted the 15th annual BIO CEO & Investor Conference at the Waldorf Astoria New York, the largest investor conference focused on established and emerging publicly traded and select private biotech companies.
BioCentury This Week
SOYBEANS TO STEM CELLS — How Supreme Court ruling in Monsanto v. Bowman could affect regenerative medicine. With BIO's Hans Sauer; Bowman attorney Edgar Haug; George Kimbrell of Center for Food Safety; Gary Baise, representing the American Soybean Association.
Biotech Crops
Farmers around the world continue to adopt genetically engineered (GE) crops because of their tremendous environmental, economic benefits, and their ability to contribute to food security, according to a report released by the International Service for the Acquisition of Agri-Biotech Applications.
BIO International Convention
As the BIO International Convention celebrates its 20th year, there is no time like the present to reflect on the evolution of the world’s largest biotechnology industry gathering, and what it illustrates in terms of the patterns of global industry achievements.
- Global Policy Platform
- BIO CEO & Investor Conference
- BioCentury This Week
- Biotech Crops
- BIO International Convention
What is Biotechnology?
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We have used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.
Want to learn more about how Biotechnology is healing, feeding and fueling the world?
Highlights
Congress created the 340B program in 1992 to help uninsured indigent patients gain better access...
|
Biotechnology can help society solve old problems in new ways. Through the science of using...
|
At a time when the global economy struggles to recover from a severe recession and uncertainty...
|
-
***BIO Board Members please follow this link*** Once a year, BIO hosts the Legislative Day Fly-In, inviting biotechnology executives from across...
-
Over the past nine years, BIO's semiannual IP Counsels Committee Conference has become a popular and growing event among our members...
-
April 19-21, 2013 Hilton Chicago Hotel 720 South Michigan Avenue Chicago, IL 60605 Co-located with the 2013 BIO International Convention...
-
The BIO World Congress on Industrial Biotechnology is the world's largest industrial biotechnology event for business leaders, investors,...
-
Building Innovative Collaborations Across the Pacific The seventh annual Pacific Rim Summit on Industrial Biotechnology and Bioenergy is the...
Jim Greenwood on the Road:
Communicating the Biotechnology Message
Javascript is required to view this map.
Last Visited Location
New York City
The Waldorf Astoria, United States | Feb 12 2013
"For the health care industry our version of sequestration, over the long-term, is IPAB (the Independent Payment Advisory Board) - which we loathe. It was part of the Affordable Care Act, or Obamacare, and it's an unelected group of folks who get to make tough decisions about cutting Medicare. We are bent on repealing it."
Jim Greenwood moderated a panel at the 15th Annual BIO CEO & Investor Conference that featured Joshua Bolten and John Podesta, two former White House Chiefs of Staff who have served in the trenches under President George W. Bush and President Bill Clinton.
Learn more about the BIO CEO & Investor Conference
Read our session coverage on BIOtechNOW
Business Solutions Sponsor
